Aspen Aerogels (NYSE:ASPN) Price Target Cut to $33.00

Aspen Aerogels (NYSE:ASPN) had its price target reduced by Piper Sandler from $36.00 to $33.00 in a report published on Tuesday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the construction company’s stock.

Several other research firms have also recently commented on ASPN. TD Cowen boosted their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Barclays started coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective on the stock. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Benchmark reiterated a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. Finally, Roth Mkm reiterated a “buy” rating and issued a $36.00 price target on shares of Aspen Aerogels in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $29.40.

Aspen Aerogels Trading Down 2.1 %

Shares of NYSE ASPN opened at $19.00 on Tuesday. The company’s fifty day moving average is $25.51 and its 200-day moving average is $24.46. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of -43.17 and a beta of 2.16. Aspen Aerogels has a twelve month low of $7.17 and a twelve month high of $33.15. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. The business had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm’s revenue was up 144.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.22) EPS. Equities research analysts predict that Aspen Aerogels will post 0.21 EPS for the current year.

Insider Transactions at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Driehaus Capital Management LLC boosted its holdings in Aspen Aerogels by 130.4% in the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after purchasing an additional 1,220,724 shares during the period. American Century Companies Inc. boosted its holdings in Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after purchasing an additional 654,350 shares during the period. Millennium Management LLC bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $9,339,000. Hood River Capital Management LLC boosted its holdings in Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after purchasing an additional 357,895 shares during the period. Finally, Renaissance Technologies LLC bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $8,340,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.